Because S80A mutant mice were able to mount a normal acute wound repair response to toxic liver injury yet were at least partially protected from fibrosis in the context of chronic liver damage, targeting translational modification events on Mecp2 may offer a therapeutic strategy in fibrosis. The gene discussed is MECP2; the disease is fibrosis.